Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling.

David P Nicolau1

  • 1Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, P.O. Box 5037, Hartford, CT 06102-5037, USA. dnicola@harthosp.org

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|December 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Xpert Carba-R NxG Assay for Detection of Carbapenemase Genes in a Global Challenge Set of Pseudomonas aeruginosa Isolates.

Journal of clinical microbiology·2020
Same author

Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection model.

The Journal of antimicrobial chemotherapy·2020
Same author

Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms.

Current opinion in infectious diseases·2020
Same author

Variability in Zinc Concentration among Mueller-Hinton Broth Brands: Impact on Antimicrobial Susceptibility Testing of Metallo-β-Lactamase-Producing <i>Enterobacteriaceae</i>.

Journal of clinical microbiology·2020
Same author

Bactericidal In Vitro Activity of a Tissue-Achievable Concentration of Cefazolin against Methicillin-Resistant <i>Staphylococcus aureus</i>.

Surgical infections·2020
Same author

In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria.

The Journal of antimicrobial chemotherapy·2020
Same journal

Device-Associated Infection Surveillance in Japan: 2025 Annual Report of the Japanese Society for Infection Prevention and Control.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Letter to the editor: Sex-stratified urinalysis thresholds and pre-analytic comparability in urine culture prediction.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Clinical Characteristics of Providencia rettgeri Bacteraemia and Antimicrobial Susceptibility Patterns.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Therapeutic drug monitoring-guided linezolid salvage therapy for Lacticaseibacillus paracasei infective endocarditis: A case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Comprehensive risk assessment and evaluation of the impact of amino acid preparations on peripheral line-associated bloodstream infection: A single-center retrospective observational study using propensity score matching.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Respiratory syncytial virus outcomes and duration of protection following nirsevimab administration in high-risk infants: a real-world study under year-round epidemic circulation in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
See all related articles

Optimizing antimicrobial therapy requires understanding host, pathogen, and drug interactions. Pharmacodynamic profiling, using methods like Monte Carlo simulation, helps maximize drug effectiveness while minimizing resistance.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Effective antimicrobial treatment hinges on optimizing host-pathogen-drug interactions.
  • Minimizing microbial resistance is crucial alongside maximizing treatment effectiveness.

Purpose of the Study:

  • To explore how pharmacodynamic profiling can optimize antimicrobial drug use.
  • To highlight the importance of understanding drug-host-pathogen dynamics in infection treatment.

Main Methods:

  • Utilizing Monte Carlo simulations to integrate in vitro potency (MICs) with pharmacokinetic profiles.
  • Assessing key pharmacodynamic parameters: Cmax:MIC, AUC:MIC, and T > MIC.

Main Results:

  • Different antimicrobials have varying optimal pharmacodynamic targets (e.g., Cmax:MIC for aminoglycosides, AUC:MIC for fluoroquinolones, T > MIC for beta-lactams).

Related Experiment Videos

  • Concentration-dependent eradication is linked to high Cmax:MIC or AUC:MIC ratios, requiring maximized drug exposure.
  • Time-dependent eradication is linked to T > MIC, necessitating optimized duration of exposure.

    • Conclusions:

    • Appreciation of pharmacodynamic profiling is key to optimizing the use of existing antimicrobial agents.
    • Tailoring antimicrobial regimens based on pharmacodynamic principles can improve treatment outcomes and combat resistance.